Pfizer plots euro-sterling bond sale

Pfizer plans to sell a benchmark-sized four-part bond denominated in euros and sterling, one of the banks managing the sale said. Proceeds from the sale of the bonds, which will consist of four-year, seven-year and 12-year euro-denominated tranches and a 29-year sterling-denominated bond, will help fund its $68 billion takeover of Wyeth. Report

Suggested Articles

Imbruvica has enjoyed a nice run in previously untreated CLL over the last few years. But major competition is here in the form of AZ's Calquence.

Pennsylvania's Supreme Court revived thousands of lawsuits alleging the antipsychotic med Risperdal caused males to develop breasts.

In the asthma biologics race, there doesn't appear to be a clear favorite among Xolair, Dupixent, Fasenra and Nucala for a group of pulmonologists.